Welcome to
RBP World!
Drugs target to PSMC2
Drug name | Drug type | Disease/phenotype | Mechanism of action(MoA) | Phase | Status | Source |
---|---|---|---|---|---|---|
OPROZOMIB | Small molecule | multiple myeloma | 26S proteosome inhibitor | 1.0 | Completed | ClinicalTrials |
OPROZOMIB | Small molecule | neoplasm | 26S proteosome inhibitor | 1.0 | Completed | ClinicalTrials |
OPROZOMIB | Small molecule | hepatocellular carcinoma | 26S proteosome inhibitor | 1.0 | Withdrawn | ClinicalTrials |
OPROZOMIB | Small molecule | cancer | 26S proteosome inhibitor | 1.0 | Terminated | ClinicalTrials |
OPROZOMIB | Small molecule | Waldenstrom macroglobulinemia | 26S proteosome inhibitor | 1.0 | Terminated | ClinicalTrials |
OPROZOMIB | Small molecule | multiple myeloma | 26S proteosome inhibitor | 1.0 | Terminated | ClinicalTrials |